Chronic Administration of the N-Methyl-D-Aspartate Receptor Antagonist Ketamine Improves Rett Syndrome Phenotype
- 1 May 2016
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 79 (9) , 755-764
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Rett syndrome: a complex disorder with simple rootsNature Reviews Genetics, 2015
- Rett syndrome: Revised diagnostic criteria and nomenclatureAnnals of Neurology, 2010
- Breathing disorders in Rett syndrome: Progressive neurochemical dysfunction in the respiratory network after birthRespiratory Physiology & Neurobiology, 2009
- The Story of Rett Syndrome: From Clinic to NeurobiologyNeuron, 2007
- Rett syndrome in Australia: A review of the epidemiologyThe Journal of Pediatrics, 2006
- Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndromeNeurobiology of Disease, 2006
- Clinical manifestations and stages of rett syndromeMental Retardation and Developmental Disabilities Research Reviews, 2002
- A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndromeNature Genetics, 2001
- Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in miceNature Genetics, 2001
- Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2Nature Genetics, 1999